We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
134 hedge funds and large institutions have $442M invested in Amphastar Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
433% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 6
28% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 36
24% more funds holding
Funds holding: 108 → 134 (+26)
11% more capital invested
Capital invested by funds: $397M → $442M (+$45.3M)
3.6% more ownership
Funds ownership: 44.61% → 48.21% (+3.6%)
Holders
134
Holders Change
+26
Holders Change %
+24.07%
% of All Funds
2.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
46
Reduced
36
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$12M |
| 2 |
Renaissance Technologies
New York
|
+$2.44M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$2.41M |
| 4 |
MCM
Matarin Capital Management
New York
|
+$2.39M |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$1.93M |
Top Sellers
| 1 |
MSL
Mackay Shields LLC
New York
|
-$2.41M |
| 2 |
Goldman Sachs
New York
|
-$1.22M |
| 3 |
BlackRock
New York
|
-$1.2M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.01M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$682K |
